A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult

Justin C. Kao, Teerin Liewluck, Margherita Milone

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report a 58-year-old woman with slowly progressive facio-scapulo-peroneal muscle weakness due to congenital nemaline myopathy (NM) caused by a novel ACTA1 mutation (c.118A>G, p.Met271Val). In adult patients, congenital NM should be distinguished from sporadic late-onset nemaline myopathy (SLONM), which is a treatable acquired muscle disease often associated with monoclonal gammopathy or HIV infection. Both congenital NM and SLONM are characterized by the presence of nemaline rods in muscle. The patient's clinical history of difficulty running since childhood and weakness in other family members favored a congenital NM. The type 1 fiber atrophy and clusters of rods in normal size muscle fibers supported the diagnosis of congenital NM and prompted genetic molecular testing, which led to discovery of the novel ACTA1 variant causative of the myopathy.

Original languageEnglish (US)
JournalJournal of Clinical Neuroscience
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Nemaline Myopathies
Muscular Diseases
Myotonia Congenita
Mutation
Muscles
Paraproteinemias
Muscle Weakness
Genetic Testing
HIV Infections
Atrophy

Keywords

  • ACTA1
  • Nemaline myopathy
  • SLONM
  • Sporadic late onset nemaline myopathy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult. / Kao, Justin C.; Liewluck, Teerin; Milone, Margherita.

In: Journal of Clinical Neuroscience, 01.01.2018.

Research output: Contribution to journalArticle

@article{860385fd62874d62a6d976be33b759aa,
title = "A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult",
abstract = "We report a 58-year-old woman with slowly progressive facio-scapulo-peroneal muscle weakness due to congenital nemaline myopathy (NM) caused by a novel ACTA1 mutation (c.118A>G, p.Met271Val). In adult patients, congenital NM should be distinguished from sporadic late-onset nemaline myopathy (SLONM), which is a treatable acquired muscle disease often associated with monoclonal gammopathy or HIV infection. Both congenital NM and SLONM are characterized by the presence of nemaline rods in muscle. The patient's clinical history of difficulty running since childhood and weakness in other family members favored a congenital NM. The type 1 fiber atrophy and clusters of rods in normal size muscle fibers supported the diagnosis of congenital NM and prompted genetic molecular testing, which led to discovery of the novel ACTA1 variant causative of the myopathy.",
keywords = "ACTA1, Nemaline myopathy, SLONM, Sporadic late onset nemaline myopathy",
author = "Kao, {Justin C.} and Teerin Liewluck and Margherita Milone",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jocn.2018.04.044",
language = "English (US)",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult

AU - Kao, Justin C.

AU - Liewluck, Teerin

AU - Milone, Margherita

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We report a 58-year-old woman with slowly progressive facio-scapulo-peroneal muscle weakness due to congenital nemaline myopathy (NM) caused by a novel ACTA1 mutation (c.118A>G, p.Met271Val). In adult patients, congenital NM should be distinguished from sporadic late-onset nemaline myopathy (SLONM), which is a treatable acquired muscle disease often associated with monoclonal gammopathy or HIV infection. Both congenital NM and SLONM are characterized by the presence of nemaline rods in muscle. The patient's clinical history of difficulty running since childhood and weakness in other family members favored a congenital NM. The type 1 fiber atrophy and clusters of rods in normal size muscle fibers supported the diagnosis of congenital NM and prompted genetic molecular testing, which led to discovery of the novel ACTA1 variant causative of the myopathy.

AB - We report a 58-year-old woman with slowly progressive facio-scapulo-peroneal muscle weakness due to congenital nemaline myopathy (NM) caused by a novel ACTA1 mutation (c.118A>G, p.Met271Val). In adult patients, congenital NM should be distinguished from sporadic late-onset nemaline myopathy (SLONM), which is a treatable acquired muscle disease often associated with monoclonal gammopathy or HIV infection. Both congenital NM and SLONM are characterized by the presence of nemaline rods in muscle. The patient's clinical history of difficulty running since childhood and weakness in other family members favored a congenital NM. The type 1 fiber atrophy and clusters of rods in normal size muscle fibers supported the diagnosis of congenital NM and prompted genetic molecular testing, which led to discovery of the novel ACTA1 variant causative of the myopathy.

KW - ACTA1

KW - Nemaline myopathy

KW - SLONM

KW - Sporadic late onset nemaline myopathy

UR - http://www.scopus.com/inward/record.url?scp=85046713162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046713162&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2018.04.044

DO - 10.1016/j.jocn.2018.04.044

M3 - Article

C2 - 29731279

AN - SCOPUS:85046713162

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -